BIO Announces Speakers for 2007 World Congress on Industrial Biotechnology and Bioprocessing.Venture capitalist Venture Capitalist An investor who provides capital to either start-up ventures or support small companies who wish to expand but do not have access to public funding. Notes: Venture capitalists usually expect higher returns for the additional risks taken. Vinod Khosla Vinod Khosla (born January 28, 1955 in Pune, India[1]) is an Indian-American venture capitalist. He is an influential personality in Silicon Valley. He was one of the co-founders of Sun Microsystems and became a general partner of the venture capital firm Kleiner, , Scientist of the Year Jay Keasling Dr. Jay D. Keasling is a Professor of Chemical Engineering and Bioengineering at the University of California, Berkeley. He is also the Director of the Physical Biosciences Division of the Lawrence Berkeley National Laboratory, and is the Founding Director of the Synthetic Biology to address World Congress; Media registration now available online WASHINGTON -- The Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
Industrial biotechnology (known mainly in Europe as white biotechnology and Bioprocessing. Plenary speakers will examine both the next-generation scientific breakthroughs and the public-private investment policies needed to make large-scale production of biofuels a reality in the United States. Venture capitalist Vinod Khosla and Assistant Secretary for Energy Efficiency and Renewable Energy Andy Karsner will address the opening lunch plenary session on Thursday March 22. Khosla is the head of Khosla Ventures, a company that actively invests in breakthrough scientific work in clean technology areas such as biorefineries for energy and bioplastics, solar, and other environmentally friendly technologies. Fortune magazine recently called Khosla one of the nation's most influential ethanol advocates. Karsner manages the Department of Energy's $1.17 billion program to promote the development and marketplace integration of renewable and environmentally sound energy technologies and the preservation and efficient use of our nation's other valuable resources. Dr. Jay Keasling will address the lunch plenary session on Friday, March 23. Keasling's work in synthetic biology recently earned him the title of Discover magazine's 2006 Scientist of the Year. As director of the Berkeley Center for Synthetic Biology, Keasling's research seeks to expand the biotechnology process from expressing single proteins within cells to recreating complex chemical processes within engineered organisms. Keasling engineered a yeast into a chemical factory to produce a precursor to artemisinin Artemisinin (IPA: [artɛˈmɪsɪnən]) is a drug used to treat multi-drug resistant strains of falciparum malaria. , the most effective and expensive anti-malarial drug. Since artemisinin is a hydrocarbon, this work has led him into study of the production of biofuels. The Congress, to be held March 21-24, 2007 at the Walt Disney World Swan The Walt Disney World Swan is resort hotel designed by architect Michael Graves located between Epcot and Disney-MGM Studios behind Disney's BoardWalk Resort and across from its sister resort, the Walt Disney World Dolphin. and Dolphin Resort in Orlando, Fla., is hosted by BIO, the American Chemical Society The American Chemical Society (ACS) is a learned society (professional association) based in the United States that supports scientific inquiry in the field of chemistry. Founded in 1876 at New York University, the ACS currently has over 160,000 members at all degree-levels and in , the National Agricultural Biotechnology Council, the European Federation of Biotechnology The European Federation of Biotechnology (EFB) is a non-profit association of Learned Societies, Universities, Institutes, Companies and Individuals who are interested in the promotion of Biotechnology throughout Europe and also beyond. , BIOTECanada and EuropaBIO. Advance media registration for the 2007 World Congress on Industrial Biotechnology and Bioprocessing is now available online. Registration is complimentary for credentialed members of the news media. To register, please visit http://www.bio.org/worldcongress/media/. Only reporters and editors working full-time for print or broadcast news organizations may register onsite with valid media credentials. All freelancers and online publications must register in advance by 5:00 p.m. ET Thursday, March 15, 2007. BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. BIO CEO & Investor Conference Feb. 12-14, 2007, New York City 2007 World Congress on Industrial Biotechnology and Bioprocessing March 21-24, 2007, Orlando, Fla. BIO International Convention May 6-9, 2007, Boston |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion